Evidence map›Paper›PMID 39387744›Full record

ArticleJACC. Clinical electrophysiology2024

Serum Potassium Monitoring Using AI-Enabled Smartwatch Electrocardiograms.

I-Min Chiu, Po-Jung Wu, Huan Zhang, J Weston Hughes, Albert J Rogers, Laleh Jalilian, Marco Perez, Chun-Hung Richard Lin, Chien-Te Lee, James Zou and 1 more

Abstract read
In one paragraph

Article in JACC. Clinical electrophysiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

I-Min ChiuDepartment of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA; Department of Emergency Medicine, Chang Gung Memorial Hospital Kaohsiung Branch, Kaohsiung, Taiwan; Department of Computer Science and Engineering, National Sun Yat-sen University, Kaohsiung, Taiwan.
Po-Jung WuDivision of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Huan ZhangDepartment of Computer Science and Engineering, National Sun Yat-sen University, Kaohsiung, Taiwan.
J Weston HughesDepartment of Computer Science, Stanford University, Palo Alto, California, USA.
Albert J RogersDepartment of Medicine and Cardiovascular Institute, Stanford University School of Medicine, Stanford, California, USA.
Laleh JalilianDepartment of Anesthesiology and Perioperative Medicine, University of California-Los Angeles, Los Angeles, California, USA.
Marco PerezDepartment of Medicine and Cardiovascular Institute, Stanford University School of Medicine, Stanford, California, USA.
Chun-Hung Richard LinDepartment of Computer Science and Engineering, National Sun Yat-sen University, Kaohsiung, Taiwan.
Chien-Te LeeDivision of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Kaohsiung Municipal Feng-Shan Hospital, Kaohsiung, Taiwan.
James ZouDepartment of Biomedical Data Science, Stanford University, Palo Alto, California, USA.
David OuyangDepartment of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA. Electronic address: david.ouyang@cshs.org.

Funding

Deep Learning Assessment of the Right Ventricle: Function, Etiology, and PrognosisR00HL157421 · NHLBI · KAISER FOUNDATION RESEARCH INSTITUTE · PI OUYANG, DAVID · 2023 to 2025
$747k
Electrical Mapping Signatures of Adverse Structural and Functional Remodeling in Ventricular ArrhythmiaK23HL166977 · NHLBI · STANFORD UNIVERSITY · PI Albert Joseph Rogers · 2023 to 2026
$680k
NHLBI NIH HHS K23 HL166977NHLBI NIH HHS L30 HL143631NHLBI NIH HHS R00 HL157421
6 · The paper itself

Abstract

backgroundHyperkalemia, characterized by elevated serum potassium levels, heightens the risk of sudden cardiac death, particularly increasing risk for individuals with chronic kidney disease and end-stage renal disease (ESRD). Traditional laboratory test monitoring is resource-heavy, invasive, and unable to provide continuous tracking. Wearable technologies like smartwatches with electrocardiogram (ECG) capabilities are emerging as valuable tools for remote monitoring, potentially allowing for personalized monitoring with artificial intelligence (AI)-ECG interpretation.

objectivesThe purpose of this study was to develop an AI-ECG algorithm to predict serum potassium level in ESRD patients with smartwatch-generated ECG waveforms.

methodsA cohort of 152,508 patients with 293,557 ECGs paired serum potassium levels obtained within 1 hour at Cedars Sinai Medical Center was used to train an AI-ECG model ("Kardio-Net") to predict serum potassium level. The model was further fine-tuned on 4,337 ECGs from 1,463 patients with ESRD using inputs from 12- and single-lead ECGs. Kardio-Net was evaluated in held-out test cohorts from Cedars Sinai Medical Center and Stanford Healthcare (SHC) as well as a prospective international cohort of 40 ESRD patients with smartwatch ECGs at Chang Gung Memorial Hospital.

resultsThe Kardio-Net, when applied to 12-lead ECGs, identified severe hyperkalemia (>6.5 mEq/L) with an AUC of 0.852 (95% CI: 0.745-0.956) and a mean absolute error (MAE) of 0.527 mEq/L. In external validation at SHC, the model achieved an AUC of 0.849 (95% CI: 0.823-0.875) and an MAE of 0.599 mEq/L. For single-lead ECGs, Kardio-Net detected severe hyperkalemia with an AUC of 0.876 (95% CI: 0.765-0.987) in the primary cohort and had an MAE of 0.575 mEq/L. In the external SHC validation, the AUC was 0.807 (95% CI: 0.778-0.835) with an MAE of 0.740 mEq/L. Using prospectively obtained smartwatch data, the AUC was 0.831 (95% CI: 0.693-0.975), with an MAE of 0.580 mEq/L.

conclusionsWe validate a deep learning model to predict serum potassium levels from both 12-lead ECGs and single-lead smartwatch data, demonstrating its utility for remote monitoring of hyperkalemia.

Indexed as

Artificial IntelligenceElectrocardiographyHyperkalemiaPotassiumWearable Electronic DevicesAdultAgedAlgorithmsFemaleHumansKidney Failure, ChronicMaleMiddle AgedPotassiumApple Watchartificial intelligenceelectrocardiogramshyperkalemiapotassium monitoringsmart watch

Identifiers

PMID39387744
PMCPMC13549449

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.